Polar Capital’s Bio-Techne TECH Stock Holding History

Polar Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,776	Closed	-$274K	–	316
2020 Q1	$274K	Buy	+5,776	New	+$289K	﹤0.01%	283

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Polar Capital's TECH Position: Q2 2020 in Review

Polar Capital sold out of Bio-Techne (TECH) in Q2 2020, closing a stake of 5,776 shares — an estimated $274K sold.

Polar Capital first reported a position in TECH in Q1 2020 and held it in 1 quarter. The position peaked at $274K in Q1 2020. 393 funds tracked by Wall St. Rank hold TECH as of Q2 2020.

Polar Capital reported no remaining Bio-Techne position as of Q2 2020 after selling out during the quarter.
Polar Capital sold 5,776 Bio-Techne shares in Q2 2020, an estimated $274K.
Polar Capital first reported a position in Bio-Techne in Q1 2020 and held it in 1 quarter.
Polar Capital's Bio-Techne position peaked at $274K in Q1 2020.
393 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.